Dr. Kevin Whitehead, MD

Claim this profile

University of Utah Healthcare

Studies Telangiectasia
Studies Hereditary Hemorrhagic Telangiectasia (HHT)
3 reported clinical trials
4 drugs studied

Affiliated Hospitals

Image of trial facility.
University Of Utah Health Care
Image of trial facility.
University Of Utah Medical Center

Clinical Trials Kevin Whitehead, MD is currently running

Image of trial facility.

Pazopanib

for Hereditary Hemorrhagic Telangiectasia

During the Efficacy Study (Part B), the investigators will study whether Pazopanib, taken daily for 24 weeks, will reduce the severity of nose bleeds in patients with hereditary hemorrhagic telangiectasia (HHT). Patients will either be provided active drug or a placebo \[sugar - inactive pill\], and be tested for nose bleed severity throughout the trial, including particularly nose bleed duration. Investigators will also test for blood loss, as well as for safety. This study is funded by the US Department of Defense USAMRAA and FDA/OOPD.
Recruiting0 awards Phase 2 & 3

More about Kevin Whitehead, MD

Clinical Trial Related4 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Kevin Whitehead, MD has experience with
  • Pomalidomide
  • Placebo
  • Pazopanib
  • Placebo Oral Capsule
Breakdown of trials Kevin Whitehead, MD has run
Telangiectasia
Hereditary Hemorrhagic Telangiectasia (HHT)
Nosebleed
Osler-Weber-Rendu Syndrome
Anemia

Other Doctors you might be interested in

Estelle Harris, MDUniversity of Utah Hospitals & Clinics
Bradley Yoder, MDUniversity of Utah
Ryan Metcalf, MDUniversity of Utah

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Kevin Whitehead, MD specialize in?
Kevin Whitehead, MD focuses on Telangiectasia and Hereditary Hemorrhagic Telangiectasia (HHT). In particular, much of their work with Telangiectasia has involved treating patients, or patients who are undergoing treatment.
Is Kevin Whitehead, MD currently recruiting for clinical trials?
Yes, Kevin Whitehead, MD is currently recruiting for 1 clinical trial in Salt Lake City Utah. If you're interested in participating, you should apply.
Are there any treatments that Kevin Whitehead, MD has studied deeply?
Yes, Kevin Whitehead, MD has studied treatments such as Pomalidomide, Placebo, Pazopanib.
What is the best way to schedule an appointment with Kevin Whitehead, MD?
Apply for one of the trials that Kevin Whitehead, MD is conducting.
What is the office address of Kevin Whitehead, MD?
The office of Kevin Whitehead, MD is located at: University of Utah Healthcare, Salt Lake City, Utah 84132 United States. This is the address for their practice at the University of Utah Healthcare.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top